Source map — Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Fierce Biotech | news | 60% |
| Reuters | news | 60% |
| Endpoints News | news | 60% |
| PR Newswire | news | 60% |
| Investor's Business Daily | news | 60% |
| Amgen | news | 60% |
| GuruFocus | news | 60% |
| www.sjogrensadvocate.com | news | 50% |
| www.cbssports.com | news | 50% |
| www.ad-hoc-news.de | news | 50% |
| www.marketbeat.com | news | 50% |
| www.compuserve.com | news | 50% |
| crweworld.com | news | 50% |
| www.rheumatologyadvisor.com | news | 50% |
| www.marketscreener.com | news | 50% |
| www.ajmc.com | news | 50% |
| simplywall.st | news | 50% |
| biotechmorning.com | news | 50% |
| finance.yahoo.com | news | 50% |
| rheumnow.com | news | 50% |
| el7.ai | news | 50% |
| guavy.com | news | 50% |
| www.chemdiv.com | news | 50% |
| www.europeanpharmaceuticalreview.com | news | 50% |
| www.finanznachrichten.de | news | 50% |